sotatercept
merck
['stellar', 'sotatercept']
the phase 3 stellar trial indicates adding sotatercept to background therapy in pah was associated with statistically significant improvements in 6-minute walk distance and 8 of the trial's 9 secondary endpoints. #acc2023 #hypertension
Clinical News for Connected Physicians. Everything you need to enhance your clinical approach to improving patient care.